1 / 11

Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pi

"Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014”, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)s therapeutic pipeline. For more details : http://goo.gl/ToQeMl

Shubhangi
Télécharger la présentation

Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 www.aarkstore.com

  2. Summary “Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014”, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency)s therapeutic pipeline. This Market Research Report provides comprehensive information on the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibrinogen Deficiency (Factor I Deficiency) and special features on late-stage and discontinued projects. www.aarkstore.com www.aarkstore.com

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Fibrinogen Deficiency (Factor I Deficiency) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Fibrinogen Deficiency (Factor I Deficiency) and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Fibrinogen Deficiency (Factor I Deficiency) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Fibrinogen Deficiency (Factor I Deficiency) pipeline on the basis of target, MoA, route of administration and molecule type www.aarkstore.com www.aarkstore.com

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Fibrinogen Deficiency (Factor I Deficiency) - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Fibrinogen Deficiency (Factor I Deficiency) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.aarkstore.com www.aarkstore.com

  5. Table of Contents IntroductionREPORT COVERAGEFibrinogen Deficiency (Factor I Deficiency) OverviewTherapeutics DevelopmentPipeline Products for Fibrinogen Deficiency (Factor I Deficiency) - OverviewPipeline Products for Fibrinogen Deficiency (Factor I Deficiency) - Comparative AnalysisFibrinogen Deficiency (Factor I Deficiency) - Therapeutics under Development by CompaniesFibrinogen Deficiency (Factor I Deficiency) - Pipeline Products GlanceLate Stage ProductsClinical Stage ProductsFibrinogen Deficiency (Factor I Deficiency) - Products under Development by CompaniesFibrinogen Deficiency (Factor I Deficiency) - Companies Involved in Therapeutics DevelopmentBiotest AGChina Biologic Products, Inc. www.aarkstore.com www.aarkstore.com

  6. List Of Tables Number of Products under Development for Fibrinogen Deficiency (Factor I Deficiency), H2 2014Number of Products under Development for Fibrinogen Deficiency (Factor I Deficiency) - Comparative Analysis, H2 2014Number of Products under Development by Companies, H2 2014Comparative Analysis by Late Stage Development, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Products under Development by Companies, H2 2014Fibrinogen Deficiency (Factor I Deficiency) - Pipeline by Biotest AG, H2 2014Fibrinogen Deficiency (Factor I Deficiency) - Pipeline by China Biologic Products, Inc., H2 2014Fibrinogen Deficiency (Factor I Deficiency) - Pipeline by LFB S.A., H2 2014 www.aarkstore.com

  7. List Of Figures Number of Products under Development for Fibrinogen Deficiency (Factor I Deficiency), H2 2014Number of Products under Development by Companies, H2 2014Comparative Analysis by Clinical Stage Development, H2 2014Assessment by Monotherapy Products, H2 2014Number of Products by Stage and Top 10 Targets, H2 2014Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014Number of Products by Top 10 Routes of Administration, H2 2014Number of Products by Stage and Top 10 Routes of Administration, H2 2014Number of Products by Stage and Top 10 Molecule Types, H2 2014 www.aarkstore.com

  8. Related Market Research reports: • Blirt S.A. - Product Pipeline Review – 2014 • Auris Medical Holding AG - Product Pipeline Review – 2014 • Integral Molecular, Inc. - Product Pipeline Review – 2014 • DaVinci Biosciences, LLC - Product Pipeline Review – 2014 • Actavis plc - Product Pipeline Review - 2014 www.aarkstore.com

  9. Related Market Research reports: • TiGenix NV - Product Pipeline Review – 2014 • Egenix, Inc. - Product Pipeline Review – 2014 • SkyePharma PLC - Product Pipeline Review – 2014 • MediWound Ltd. - Product Pipeline Review – 2014 • BioTech Tools s.a. - Product Pipeline Review - 2014 www.aarkstore.com

  10. Aarkstore - Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 www.aarkstore.com

  11. Contact Us Office Office No. - 809, 8th Floor, B-Wing, Mahaavir Icon,  Plot No.- 89 & 90, Sector-15, CBD-Belapur, Navi Mumbai – 400614,  Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit : http://www.aarkstore.com OR Mail us at : contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com

More Related